Windber Taps InforSense to Help Build Bedside to Bench Informatics Platform | GenomeWeb

The Windber Research Institute is aiming to move beyond the conventional concept of translational medicine, according to CSO Michael Liebman. "Translational medicine is always spoken of as going from the bench to the bedside," he said, "but we try to emphasize it also going from the bedside to the bench, because if we don't do it in that reverse direction, then the basic researchers don't know really what problems should be solved."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.